Fifth Third Bancorp
TGTX icon

Fifth Third Bancorp’s TG Therapeutics TGTX Stock Holding History

Fifth Third Bancorp’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.35M Buy
60,926
+29,167
+92% +$1.19M 0.01% 1005
2026
Q1 		$1.06M Buy
31,759
+31,018
+4,186% +$924K ﹤0.01% 1601
2025
Q4 		$22.1K Buy
741
+60
+9% +$1.96K ﹤0.01% 1844
2025
Q3 		$24.6K Buy
681
+79
+13% +$2.6K ﹤0.01% 1808
2025
Q2 		$21.7K Sell
602
-104
-15% -$3.87K ﹤0.01% 1747
2025
Q1 		$27.8K Buy
706
+254
+56% +$8.55K ﹤0.01% 1643
2024
Q4 		$13.6K Buy
452
+95
+27% +$2.73K ﹤0.01% 1893
2024
Q3 		$8.35K Buy
+357
New +$7.8K ﹤0.01% 2055
2023
Q4 		– Sell
-1,305
Closed -$10.9K – 2656
2023
Q3 		$10.9K Sell
1,305
-3,264
-71% -$45.5K ﹤0.01% 1932
2023
Q2 		$113K Hold
4,569
– – ﹤0.01% 1111
2023
Q1 		$68.7K Hold
4,569
– – ﹤0.01% 1326
2022
Q4 		$54.1K Hold
4,569
– – ﹤0.01% 1309
2022
Q3 		$27K Buy
+4,569
New +$30K ﹤0.01% 1580
2021
Q3 		– Sell
-500
Closed -$19K – 2749
2021
Q2 		$19K Buy
+500
New +$19.6K ﹤0.01% 1814
2018
Q4 		– Sell
-6,600
Closed -$37K – 2341
2018
Q3 		$37K Hold
6,600
– – ﹤0.01% 1413
2018
Q2 		$87K Buy
+6,600
New +$90.8K ﹤0.01% 1144

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Fifth Third Bancorp's TGTX Position: Q2 2026 in Review

Fifth Third Bancorp increased its TG Therapeutics (TGTX) stake by 92% in Q2 2026, buying an estimated $1.19M and bringing the position to 60,926 shares worth $3.35M. The position accounts for 0.01% of the portfolio, ranked #1005.

Fifth Third Bancorp first reported a position in TGTX in Q2 2018 and has held it in 16 quarters since. 429 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Fifth Third Bancorp held 60,926 shares of TG Therapeutics worth $3.35M as of Q2 2026.
  • Fifth Third Bancorp bought 29,167 TG Therapeutics shares in Q2 2026, an estimated $1.19M.
  • TG Therapeutics made up 0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #1005 holding.
  • Fifth Third Bancorp first reported a position in TG Therapeutics in Q2 2018 and has held it in 16 quarters since.
  • 429 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.